IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. — Investor Relations & Filings
IMEIK Technology Development Co., Ltd. focuses on the research, development, and commercialization of biomedical materials, specifically targeting the aesthetic medicine sector. The company’s primary product line consists of injectable hyaluronic acid fillers and facial implants designed for soft tissue repair and augmentation. Utilizing proprietary cross-linking technologies, the firm produces high-purity formulations such as Hi-Tech and Hearty. Its portfolio also encompasses skin repair products and solutions for minimally invasive procedures. The organization prioritizes technological innovation and maintains a robust pipeline of Class III medical device registrations. By leveraging advanced biotechnology, the company provides clinical-grade materials to medical institutions and specialized clinics, emphasizing safety, efficacy, and biocompatibility in its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事会关于证券投资情况的专项说明 | 2026-03-19 | Chinese | |
| 容诚专字[2026]100Z0927号-上市公司非经营性资金占用专项说明 | 2026-03-19 | Chinese | |
| 董事会关于对独立董事2025年度独立性评估的专项意见 | 2026-03-19 | Chinese | |
| 关于公司2023年第一期限制性股票激励计划首次授予部分第三个归属期和预留授予部分第三个归属期归属条件未成就的公告 | 2026-03-19 | Chinese | |
| 关于使用暂时闲置募集资金进行现金管理的公告 | 2026-03-19 | Chinese | |
| 2025年年度财务报告 | 2026-03-19 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38858334 | 董事会关于证券投资情况的专项说明 | 2026-03-19 | Chinese | ||
| 38858316 | 容诚专字[2026]100Z0927号-上市公司非经营性资金占用专项说明 | 2026-03-19 | Chinese | ||
| 38858315 | 董事会关于对独立董事2025年度独立性评估的专项意见 | 2026-03-19 | Chinese | ||
| 38858301 | 关于公司2023年第一期限制性股票激励计划首次授予部分第三个归属期和预留授予部分第三个归属期归属条件未成就的公告 | 2026-03-19 | Chinese | ||
| 38858298 | 关于使用暂时闲置募集资金进行现金管理的公告 | 2026-03-19 | Chinese | ||
| 38858295 | 2025年年度财务报告 | 2026-03-19 | Chinese | ||
| 38858268 | 2025年度独立董事述职报告—于玉群 | 2026-03-19 | Chinese | ||
| 38858254 | 关于召开2025年度股东会的通知 | 2026-03-19 | Chinese | ||
| 38858240 | 关于2025年度利润分配预案的公告 | 2026-03-19 | Chinese | ||
| 38858233 | 董事会审计委员会对会计师事务所2025年度履职情况评估及履行监督职责情况的报告 | 2026-03-19 | Chinese | ||
| 38858227 | 2025年年度审计报告 | 2026-03-19 | Chinese | ||
| 38858224 | 2025年年度报告 | 2026-03-19 | Chinese | ||
| 38858223 | 2025年年度报告摘要 | 2026-03-19 | Chinese | ||
| 38858221 | 中信证券股份有限公司关于爱美客技术发展股份有限公司使用暂时闲置募集资金进行现金管理的核查意见 | 2026-03-19 | Chinese | ||
| 38858218 | 关于公司全资子公司拟与关联方签订《采购框架协议》暨日常关联交易预计的公告 | 2026-03-09 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55863/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55863 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55863 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55863 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55863}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. (id: 55863)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.